Condition: Major Depressive Disorder · Sponsor: Cybin IRL Limited
The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.
This description comes directly from the study's public registry record.
Clinical Development · 877-361-4003 · clinicaltrialsinfo@cybin.com
Always discuss trial participation with your own doctor first.
| Scottsdale Research Institute | Phoenix, Arizona, United States | Recruiting |
| Mountain Clinical Trials | Phoenix, Arizona, United States | Recruiting |
| Noble Clinical Research | Tucson, Arizona, United States | Recruiting |
| Del Sol Research Management | Tucson, Arizona, United States | Recruiting |
| CenExel CIT (Clinical Innovations, Inc) | Bellflower, California, United States | Recruiting |
| Kadima Neuropsychiatry Institute | La Jolla, California, United States | Recruiting |
| Bespoke Treatment/Lipov Medical Group | Los Angeles, California, United States | Recruiting |
| Catalina Research Institute | Montclair, California, United States | Recruiting |
| Excell Research, Inc | Oceanside, California, United States | Recruiting |
| Open Mind Therapeutics | San Francisco, California, United States | Recruiting |
| Inland Psychiatric Medical Group Inc | San Juan Capistrano, California, United States | Recruiting |
| Mountain View Clinical Research | Denver, Colorado, United States | Recruiting |
+ 35 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06564818